Physician profile
Thomas Roukis
NPI 1740288356
$1,029,737.85
in general payments reported to CMS, 2019-2025
20 companies · $136K in 2025
The $136K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141K · 2020: $170K · 2021: $156K · 2022: $152K · 2023: $141K · 2024: $135K · 2025: $136K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $401K · Consulting Fee: $7,320 · Travel and Lodging: $2,054 · Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $401,466.38 |
| Consulting Fee | $7,319.74 |
| Travel and Lodging | $2,054.23 |
| Food and Beverage | $638.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $518,312.81 | 2021-2025 | Salto Talaris Total Ankle Prosthesis |
| Integra Lifesciences Corporation | $179,740.56 | 2019-2021 | |
| Novastep INC. | $125,714.01 | 2019-2025 | Nexis, Airlock, Airlock Centrolock |
| Medical Device Business Services, INC. | $94,646.49 | 2019-2022 | |
| Stryker Corporation | $22,671.09 | 2019-2025 | Subfix |
| Depuy Synthes Sales INC. | $20,413.80 | 2022-2025 | Motoband |
| Fh Orthopedics, INC. | $19,505.66 | 2019 | |
| Glw, INC | $14,159.24 | 2024-2025 | Apollo |
| In2bones USA, LLC | $13,455.14 | 2019-2022 | |
| Linvatec Corporation | $8,693.01 | 2023-2025 | Allograft Tissue, Triway, Alloaid |
| Crossroads Extremity Systems, LLC | $7,640.63 | 2019-2021 | |
| Nvision Biomedical Technologies, INC. | $2,322.34 | 2024 | Trigon |
| Team 1, LLC | $1,246.36 | 2021-2024 | |
| Ascension Orthopedics, INC. | $875.00 | 2019 | |
| Trimed, INC. | $94.04 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $79.47 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Acera Surgical, INC. | $79.29 | 2024 | Restrata Wound Matrix |
| Medartis INC. | $50.35 | 2025 | Aptus |
| Acumed LLC | $20.43 | 2025 | Acumed |
| Reel Surgical, INC. | $18.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$357,203.16 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Roukis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.